William X Chen, MD | |
1921 Brandywine Dr, Allison Park, PA 15101-3370 | |
(412) 367-1072 | |
Not Available |
Full Name | William X Chen |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Location | 1921 Brandywine Dr, Allison Park, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932173838 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | MD052467L (Pennsylvania) | Primary |
Entity Name | Anesthesia Associates Of New Mexico P C |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912900754 PECOS PAC ID: 4385536564 Enrollment ID: O20040325000455 |
News Archive
Amgen and Micromet, Inc. today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development (R&D) center in Munich and headquarters in Rockville, Md., for $11 per share in cash.
Minority and multiracial children experience many disparities in medical and oral health status, access to care, and use of services, according to a new national study by researchers at the Center for Advancement of Underserved Children at the Medical College of Wisconsin in Milwaukee and Children's Hospital of Wisconsin.
A Japanese research team has successfully developed a system to predict the severity of Alport syndrome, a serious hereditary kidney disease that occurs in about 1 out of 5,000 people in the US. Patients with Alport syndrome have abnormalities in the causative protein, type IV collagen, that often lead to chronic renal dysfunction requiring dialysis.
Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's NDA for BANZEL® (rufinamide) Oral Suspension (40 mg/mL).
› Verified 5 days ago
Entity Name | Resource Anesthesiology Associates Of Nm Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386929644 PECOS PAC ID: 0941469530 Enrollment ID: O20120319000323 |
News Archive
Amgen and Micromet, Inc. today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development (R&D) center in Munich and headquarters in Rockville, Md., for $11 per share in cash.
Minority and multiracial children experience many disparities in medical and oral health status, access to care, and use of services, according to a new national study by researchers at the Center for Advancement of Underserved Children at the Medical College of Wisconsin in Milwaukee and Children's Hospital of Wisconsin.
A Japanese research team has successfully developed a system to predict the severity of Alport syndrome, a serious hereditary kidney disease that occurs in about 1 out of 5,000 people in the US. Patients with Alport syndrome have abnormalities in the causative protein, type IV collagen, that often lead to chronic renal dysfunction requiring dialysis.
Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's NDA for BANZEL® (rufinamide) Oral Suspension (40 mg/mL).
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
William X Chen, MD 1921 Brandywine Dr, Allison Park, PA 15101-3370 Ph: (412) 367-1072 | William X Chen, MD 1921 Brandywine Dr, Allison Park, PA 15101-3370 Ph: (412) 367-1072 |
News Archive
Amgen and Micromet, Inc. today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development (R&D) center in Munich and headquarters in Rockville, Md., for $11 per share in cash.
Minority and multiracial children experience many disparities in medical and oral health status, access to care, and use of services, according to a new national study by researchers at the Center for Advancement of Underserved Children at the Medical College of Wisconsin in Milwaukee and Children's Hospital of Wisconsin.
A Japanese research team has successfully developed a system to predict the severity of Alport syndrome, a serious hereditary kidney disease that occurs in about 1 out of 5,000 people in the US. Patients with Alport syndrome have abnormalities in the causative protein, type IV collagen, that often lead to chronic renal dysfunction requiring dialysis.
Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's NDA for BANZEL® (rufinamide) Oral Suspension (40 mg/mL).
› Verified 5 days ago
Dr. Steven A Chernus, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 4485 William Flynn Hwy Ste 3, Allison Park, PA 15101 Phone: 412-492-0800 | |
Jeffrey Astbury, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4485 William Flynn Hwy, Allison Park, PA 15101 Phone: 412-492-0800 Fax: 412-492-4057 | |
Dr. Randall S Rawa, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4485 William Flynn Hwy, Suite 3, Allison Park, PA 15101 Phone: 412-492-0800 Fax: 412-492-4057 | |
Dr. John P Bray, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4485 William Flynn Hwy, Suite 3, Allison Park, PA 15101 Phone: 412-492-0800 Fax: 412-492-4057 | |
Dr. David E Hertzog, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4485 William Flynn Hwy, Suite 3, Allison Park, PA 15101 Phone: 412-492-0800 Fax: 412-492-4057 | |
Regis Switala, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4485 William Flynn Hwy, Suite 3, Allison Park, PA 15101 Phone: 412-492-0800 Fax: 412-492-4057 |